July 8, 2019 Press release - Regulatory Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma
June 18, 2019 Press release - Regulatory Targovax ASA: Registration of share capital increase following settlement of RSUs
June 13, 2019 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider following settlement of RSUs
June 12, 2019 Press release - Regulatory Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
June 6, 2019 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
June 6, 2019 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
June 5, 2019 Press release - Regulatory Targovax ASA: Completion of subsequent offering, registration of share capital increase
May 31, 2019 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
May 24, 2019 Press release - Regulatory Targovax ASA: Last day of the subscription period in the subsequent offering
May 23, 2019 Press release - Regulatory TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS
May 23, 2019 Press release - Regulatory Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer
May 10, 2019 Press release - Regulatory Targovax ASA: Commencement of subscription period in the subsequent offering
May 2, 2019 Press release - Regulatory Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
April 12, 2019 Press release - Regulatory TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS
March 28, 2019 Press release - Regulatory TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT
March 21, 2019 Press release - Regulatory TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING
March 15, 2019 Press release - Regulatory Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute